Optimizing the growth environment for a recombinant myeloma cell line used in the production of new cancer vaccines

Download

placeholder.pdf (13.94Kb) Embargoed until: 2999-01-01

Advisor

Author

Steinicke, Anthony O. S.

Accessioned

2005-07-29T23:03:59Z

Available

2005-07-29T23:03:59Z

Issued

1994

Lcc

QR 185.8 H93 S74 1994

Lcsh

Hybridomas
Monoclonal antibodies
Biochemical engineering

Type

Thesis or Dissertation, M.Sc.

Metadata

Show full item record

Place

Doi

http://dx.doi.org/10.5072/PRISM/11398

Uri

http://hdl.handle.net/1880/30363

Collections

Legacy Theses